top of page

Biosenta Announces Engagement of Oak Hill Financial Inc.

January 11, 2024 - Toronto, Canada – Biosenta Inc. (“Biosenta” or the “Company”) (CSE: ZRO), announces that it has entered into an agreement with Oak Hill Financial Inc. (“Oak Hill”) to provide business and capital markets advisory services to the Company and/or its affiliates and/or subsidiaries on a best efforts basis (the “Agreement”). Certain services to be provided by Oak Hill are anticipated to include “investor relations activities” under the policies of the Canadian Securities Exchange and applicable securities laws.

The agreement is for three months commencing January 8, 2024 (the “Effective Date”) and will automatically renew for additional 1-month terms thereafter unless written notice is provided by either party within 5 days of a renewal term. The compensation totals $10,000 plus applicable taxes on the Effective Date and every month thereafter as long as the Agreement remains in effect. The compensation does not include an option to purchase securities of the Issuer.

Oak Hill’s services will include providing solutions for investor relations programs, acting as a marketing representative on behalf of the Company to expand its shareholder base, and assisting with strategic planning and communications in investor relations materials. Oak Hill will target advisor channels of distribution and will include positioning the Company with Canadian-based Investment Advisors, sell side institutions and buy-side institutions. Oak Hill may send emails to potential investors, but the primary method of contact will ultimately be making phone calls with the goal of finding interested potential investors who would like a meeting with management. Oak Hill is located at 161 Bay Street, Suite 2460, Toronto, Ontario M5J 2S1. Its President, Marc Raffoul, can be reached at or 647-479-5803.

Oak Hill does not have any interest, directly or indirectly, in Biosenta or its securities, or any right or intent to acquire such an interest.

About Biosenta Inc.

Biosenta is a Canadian-based company that develops and manufactures a range of safe and environmentally sound chemical compounds for household and industrial applications.

For further details on the Company please see the Company's publicly available documents filed on the System for Electronic Document Analysis and Retrieval+ (SEDAR+).

Forward-Looking Statements

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation including statements regarding the terms of Oak Hill’s engagement which is based upon Biosenta's current internal expectations, estimates, projections, assumptions and beliefs, and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. The forward-looking statements are expectations only and are subject to known and unknown risks, uncertainties and other important factors that could cause actual results of the Company or industry results to differ materially from future results, performance or achievements. Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, Biosenta does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise. New factors emerge from time to time, and it is not possible for Biosenta to predict all such factors.

When considering these forward-looking statements, readers should keep in mind the risk factors and other cautionary statements as set out in the materials we file with applicable Canadian securities regulatory authorities on SEDAR+ at including our Management's Discussion and Analysis for the interim period ended June 30, 2023. These risk factors and other factors could cause actual events or results to differ materially from those described in any forward-looking information.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

SOURCE Biosenta Inc.

For further information contact:

Am Gill, President and CEO

Biosenta Inc.

Phone: 416-410-2019



bottom of page